Kuala Lumpur, 6 August 2025: Malaysia is set to host the 2nd edition of the Malaysia Pharma and Healthcare Expo (MPHC) 2025 from 7–9 October 2025 at the World Trade Centre, Kuala Lumpur, bringing together global healthcare stakeholders, government leaders, and industry innovators across the pharmaceutical, medical devices, and healthcare sectors.
Organised by Astrovision, with Ace Group (India) and Genesis Global Exhibitions as partners, and supported by the ASEAN India Economic Council (AIEC) and Malaysia India Business Council (MIBC), the three-day expo is expected to feature 100+ exhibitors from India, ASEAN, Australia, South Korea, and more.
During the official press launch, Dato’ Ramesh Kodammal, Chairman of AIEC and Goldtex Group, highlighted Malaysia’s strategic potential as a regional healthcare hub, urging stakeholders to seize growing opportunities for export, investment, and knowledge exchange. He also called for strengthened intra-Asian collaboration amidst global economic uncertainties.
Malaysia Pharma and Healthcare Expo
Key Issues to be Addressed at the Expo:
- Sustainable healthcare financing
- Public-private partnerships
- Mental health awareness
- Skilled workforce shortages
- Health policy and government roles
- Healthcare equity and accountability
Prof. Dato’ Sri Dr. Abu Hassan Asaari Abdullah, Council Member of the Malaysian Medical Council and ASEAN healthcare representative, underscored the importance of digital transformation and holistic healthcare. He encouraged greater ASEAN cooperation in emerging areas such as regenerative and aesthetic medicine, and gene therapy. “This expo aligns technology with human values, we must ensure innovation does not lose sight of compassion,” he remarked.
Datuk Surendran Menon, MIBC Secretary-General, emphasised India–Malaysia trade potential, citing bilateral trade of USD 20 billion in 2024, with pharmaceutical contributions up to USD 104 million. He highlighted Malaysia’s halal-certified manufacturing capacity and policy incentives that strengthen its appeal as a Southeast Asian gateway for Indian and global pharmaceutical companies.
The expo builds on last year’s success and recent cross-border initiatives in the Philippines and Australia. Upcoming events, including one in Malaysia on 25 September 2025 with 60+ Indian companies, further cement the country’s role in shaping the regional healthcare agenda.
Medical device sector
Meanwhile, Madam Norlela Binti Hatta @ Antah, Director at the Medical Device Authority (MDA), showcased Malaysia’s impressive medical device sector achievements (2023–2025), including:
- RM37 billion (USD 8.7 billion) in exports (2024), a 31% increase year-on-year.
- RM20 billion (USD 4.6 billion) in investments from 2021–2024.
- Successful regulatory visits to the Czech Republic, Australia, and UAE, generating millions in new investment value.
- Registration process reforms that cut review timelines for all device classes.
- Launch of digital services including Medcast 2.0, E-Certificates, and online import/export systems.
- Reliance programmes with China, Singapore, Thailand, and Indonesia to accelerate cross-border approvals.
- Leadership in the development of the ASEAN Medical Device Mutual Recognition Arrangements (MRA).
- Host of IMDEC 2024, officiated by Malaysia’s Prime Minister.
- Winner of Malaysia Management Excellence Awards (2024) and GovMedia Awards (2025).
The 2nd Malaysia Pharma and Healthcare Expo 2025 promises to be a dynamic platform for business development, policy dialogue, and regional cooperation. Innovators, manufacturers, policymakers, and healthcare professionals are invited to participate in shaping a future-ready, patient-centred healthcare ecosystem.
For Events Enquiries:
projects@genesisglobalexhibitions.com| international@genesisglobalexhibitions.com
📞 +60 178735920 / +63 9456407830
Table of Contents
Read More News on Latest Malaysia
Follow us on:
Read More News on Business News Malaysia
Read More News on SG Business News
Read More News on World Future TV
